Global Veterinary Zinc Bacitracin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture
Publisher : MRA | Format : PDF
Global Veterinary Zinc Bacitracin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Zinc Bacitracin is a mixture of high-molecular-weight polypeptides (bacitracin A, B, C, and several minor components). Zinc Bacitracin occurs as a yellowish gray-brown to brown powder. It has characteristic odor. It is freely soluble in dilute hydrochloric acid, water, pyridine, and menthol. Bacitracin has antibacterial effect on Gram-negative bacteria, actinomycetes, and leptospirae, and strong antibacterial effect on Gram-positive bacteria. It has growth-promoting effect on chickens (including broilers), pigs, and cattle.
Veterinary Zinc Bacitracin report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Zinc Bacitracin market is projected to reach US$ 170.5 million in 2033, increasing from US$ 118.3 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2033. Demand from Pigs and Cattle are the major drivers for the industry.
In 2018, Lifecome Biochemistry is considered to be the global market leader with a 26% share of production.
Top 5 manufacturers occupied about 74% market in 2018.
China was the largest production region in the past few years, with a proportion of 65%.
Asia Pacific was the largest consumption region, which occupied 1/3 market during the past few years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Veterinary Zinc Bacitracin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Zoetis
Ceva Corporate
Huvepharma
Lifecome Biochemistry
Qilu Pharmaceutical
Orion Animal Nutrition
Vega Pharma
Tianjin Xinxing Veterinary Pharmaceutical
Segment by Type
10% Zinc Bacitracin
15% Zinc Bacitracin
Pigs
Cattle
Chicken
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Zinc Bacitracin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Zinc Bacitracin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Zinc Bacitracin industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Veterinary Zinc Bacitracin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Zinc Bacitracin introduction, etc. Veterinary Zinc Bacitracin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Veterinary Zinc Bacitracin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Veterinary Zinc Bacitracin report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Zinc Bacitracin market is projected to reach US$ 170.5 million in 2033, increasing from US$ 118.3 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2033. Demand from Pigs and Cattle are the major drivers for the industry.
In 2018, Lifecome Biochemistry is considered to be the global market leader with a 26% share of production.
Top 5 manufacturers occupied about 74% market in 2018.
China was the largest production region in the past few years, with a proportion of 65%.
Asia Pacific was the largest consumption region, which occupied 1/3 market during the past few years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Veterinary Zinc Bacitracin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Zoetis
Ceva Corporate
Huvepharma
Lifecome Biochemistry
Qilu Pharmaceutical
Orion Animal Nutrition
Vega Pharma
Tianjin Xinxing Veterinary Pharmaceutical
Segment by Type
10% Zinc Bacitracin
15% Zinc Bacitracin
Segment by Application
Pigs
Cattle
Chicken
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Zinc Bacitracin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Zinc Bacitracin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Zinc Bacitracin industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Veterinary Zinc Bacitracin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Zinc Bacitracin introduction, etc. Veterinary Zinc Bacitracin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Veterinary Zinc Bacitracin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices